Cultiply, founded in 2018 and headquartered in the United States, is a pioneering entity in the Biotechnology, Life Sciences, and AgriTech industries. The company's innovative approach focuses on enhancing industrial fermentation processes through the use of bioreactors. These bioreactors serve as intelligent systems to efficiently multiply microorganisms like yeast and bacteria. The company's core mission is to provide clients with increased autonomy, lower production expenses, and assure safety in fermentative procedures.
Cultiply last secured a €40.00K Debt Financing investment from ENISA on 26 January 2021. This investment underscores its potential and credibility in the sector. The company's patented technology positions it as a crucial player in industrial advancements within its sectors. Venture capitalists may find this startup attractive for its potential to disrupt traditional fermentation processes, offering cost-effectiveness and enhanced safety for industrial applications.